Skip to main content

OrganiGram Holdings Inc

Exchange: NASDAQSector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Values in USD · ADR · Reports in CAD

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release.

Did you know?

Trading 411% below its estimated fair value of $7.25.

Current Price

$1.42

+0.71%

GoodMoat Value

$7.25

410.9% undervalued
Profile
Valuation (TTM)
Market Cap$190.93M
P/E14.27
EV
P/B0.75
Shares Out134.46M
P/Sales0.95
Revenue$201.62M
EV/EBITDA9.03

OrganiGram Holdings Inc (OGI) Financial Statements

Values in USD · ADR · Reports in CAD

OGI Financial Data

EBITDA$16.01M
Revenue (TTM)$201.62M
Gross Profit (TTM)$71.96M
Gross Margin
Operating Margin-8.44%
ROE4.73%
ROA2.93%
Debt/Equity
Current Ratio2.26
FCF$-17.75M
FCF Yield-9.30%
Piotroski F-Score
Rev/Share (TTM)$1.50
50-Day MA$1.41
200-Day MA$1.59
Shares Outstanding0.13B

OGI Computed Insights

FCF$-17.75M
FCF Growth Rate
EPS Growth (CAGR)
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

OGI Financial Statements & Data

OrganiGram Holdings Inc (OGI) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of OrganiGram Holdings Inc's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $201.62M. Gross profit (TTM) is $71.96M. EBITDA is $16.01M. Earnings per share (EPS) is $-0.14. The P/E ratio is 14.27. Market capitalization is $190.93M.

Free cash flow (FCF) is $-17.75M. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use OrganiGram Holdings Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.